Home / Stocks / Fischer Medical Venture L
FISCHER

Fischer Medical Venture L Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹22.86

Change

-0.43 (-1.85%)

Open

₹23.17

Prev. Close

₹23.29

Day High

₹23.27

Day Low

₹22.6

Volume Analysis

Traded

370,232

Delivered

210,096

Delivery %

56.75%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Promoter holding is rising

Weaknesses (2)

  • •Low return on equity (8.91%)
  • •Below-average fundamentals quality score (41/100)

Opportunities (1)

  • •FII holding has been rising

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹23.89 ₹23.58 ₹23.22 ₹22.91 ₹22.55 ₹22.24 ₹21.88
Fibonacci ₹23.58 ₹23.32 ₹23.17 ₹22.91 ₹22.65 ₹22.5 ₹22.24
Camarilla ₹23.04 ₹22.98 ₹22.92 ₹22.91 ₹22.8 ₹22.74 ₹22.68

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-44.81%

1 Week

-9.68%

1 Month

-9.03%

3 Months

-40.06%

6 Months

-37.34%

1 Year

-46.76%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Company Overview

Sector

Healthcare

Market Cap

₹1,642 Cr

P/E (TTM)

144.0

ROE

8.91%

Book Value

₹6.67

Face Value

₹1.0

Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.

TopFund Analysis

Fischer Medical Venture L scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 41/100. The strongest factor is Financial Strength (100/100), while Growth (0/100) is the weakest area to weigh before deciding. Notably: Promoter holding is rising; low return on equity (8.91%); below-average fundamentals quality score (41/100). FII holding has been rising.

TopFund Score — Fundamentals Quality

41/100 — Weak

Data confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

0

Valuation

34

Cash Flow

33

Corporate Governance

68

Momentum

6

Institutional Ownership

56

Business Quality

34

Risk & Volatility

38

Liquidity

38

From Screener.in

  • +Company is expected to give good quarter
  • +Promoter holding has increased by 0.94% over last quarter.
  • −Stock is trading at 3.55 times its book value
  • −Company has a low return on equity of 5.74% over last 3 years.
  • −Company has high debtors of 342 days.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

On 14 Nov 2026, board approved Q2 FY27 results and allotted 4.417 crore shares via warrant conversion for ₹77.5 crore.

Monitoring agency report for quarter ended September 30, 2026 shows nil deviation in preferential issue proceeds.

Newspaper advertisement regarding special window for relodgement of share transfer request

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 0 21 10 40 12 49 23 86 101 98 82 107
Expenses + 0 18 10 39 11 47 19 70 80 101 71 99
Operating Profit 0 3 0 1 0 3 4 16 22 -4 11 9
OPM % — 12.07% -2.08% 1.26% 3.15% 5.1% 17.02% 18.74% 21.34% -3.87% 13.73% 8.32%
Other Income + 0 0 1 0 0 0 7 2 1 1 1 5
Interest 0 0 0 0 0 0 1 1 1 4 4 3
Depreciation 0 0 0 0 1 1 1 1 1 1 1 1
Profit before tax 0 3 0 0 0 2 10 17 21 -8 8 9
Tax % — 6.18% 271.43% -38.1% 350.0% 26.04% 51.55% 19.51% 9.18% 64.03% 51.6% 90.86%
Net Profit + 0 3 0 0 0 1 5 14 19 -12 4 1
EPS in Rs 0 0 0 0 0 0 0 0 0 0 0 0
Raw PDF — — — — — — — — — — — —
YoY Sales growth — — — — — 137 132 118 760 98 249 25

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 0 0 0 0 0 0 0 0 0 21 111 308 388
Expenses + 0 0 0 0 0 0 0 0 0 19 107 265 350
Operating Profit 0 0 0 0 0 0 0 0 0 2 3 43 38
OPM % -300.0% — — — — -11.0% -12.0% — 11.0% 9.0% 3.0% 14.0% 10.0%
Other Income + 0 0 0 0 0 0 0 0 0 0 1 12 8
Interest 0 0 0 0 0 0 0 0 0 0 0 6 11
Depreciation 0 0 0 0 0 0 0 0 0 0 2 3 4
Profit before tax 0 0 0 0 0 0 0 0 0 2 3 47 30
Tax % 0.0% 0.0% 0.0% — 0.0% 0.0% -450.0% 20.0% — 13.0% 37.0% 33.0% —
Net Profit + 0 0 0 0 0 0 0 0 0 2 1 31 11
EPS in Rs 0 0 0 0 0 0 1 -1 0 0 0 0 0
Dividend Payout % 0.0% 0.0% 0.0% — — 0.0% 0.0% 0.0% 0.0% 0.0% 22.0% 1.0% —
Sales growth -50 -100 — — 0 -1,900 -6 -100 — 11,556 428 179 127

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves -3 -3 -4 0 0 0 0 0 0 28 274 320 396
Borrowings + 0 0 0 0 0 0 0 0 1 2 85 107 85
Other Liabilities + 0 0 0 0 0 0 0 0 0 4 34 179 199
Total Liabilities 0 0 0 0 0 0 0 0 0 86 457 671 750
Fixed Assets + 0 0 0 0 0 0 0 0 0 15 24 32 44
CWIP 0 0 0 0 0 0 0 0 0 0 1 3 2
Investments 0 0 0 0 0 0 0 0 0 1 7 118 120
Other Assets + 0 0 0 0 0 0 0 0 0 70 425 519 584
Total Assets 0 0 0 0 0 0 0 0 0 86 457 671 750
Equity Capital 3 3 3 0 0 0 0 0 0 54 64 65 70

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 0 0 0 0 0 0 0 0 — -7 -86 -101
Cash from Investing Activity + 0 0 0 0 0 0 0 0 — -29 -125 -5
Cash from Financing Activity + 0 0 0 0 0 0 0 0 — 37 315 14
Net Cash Flow 0 0 0 0 0 0 0 0 — 1 103 -92
Free Cash Flow 0 0 0 0 0 0 0 0 — -8 -91 6
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -33 42 50 0 0 -100 300 95 — -392 -2,555 -194

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 0.0% → 63.09%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 99.99% 93.24% 18.33% 18.33% 18.32% 30.51% 31.23% 31.22% 31.99% 31.51% 31.01% 28.95%
Promoters 0.0% 0.0% 74.91% 74.91% 74.91% 62.82% 61.8% 61.8% 61.8% 62.15% 62.15% 63.09%
FII 0.0% 5.07% 5.07% 5.07% 5.07% 5.23% 5.55% 5.57% 4.85% 4.97% 5.48% 6.71%
DII 0.0% 1.68% 1.68% 1.68% 1.68% 1.44% 1.42% 1.42% 1.36% 1.38% 1.35% 1.26%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Fischer Medical Venture L (this stock) 1,642 144.0 3.52 8.91%
Krsnaa Diagnostics Ltd 1,661 16.9 1.6 10.9%
Tarsons Products Limited 1,678 205.0 2.65 2.44%
Bharat Parenterals Ltd. 1,522 1227.0 4.59 -2.54%
Suraksha Diagnostic Ltd 1,780 42.6 6.45 14.2%
Ngl Fine Chem Limited 1,783 27.9 4.92 17.4%
Amrutajan Health Ltd 1,461 71.7 13.58 20.0%

Which Mutual Funds Hold Fischer Medical Venture L?

Frequently Asked Questions about Fischer Medical Venture L

Community Sentiment

What are other investors saying about Fischer Medical Venture L?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.